Frontiers in Immunology (May 2020)

IL-22 Paucity in APECED Is Associated With Mucosal and Microbial Alterations in Oral Cavity

  • Epp Kaleviste,
  • Malte Rühlemann,
  • Jaanika Kärner,
  • Liis Haljasmägi,
  • Liina Tserel,
  • Elin Org,
  • Katarina Trebušak Podkrajšek,
  • Tadej Battelino,
  • Corinna Bang,
  • Andre Franke,
  • Pärt Peterson,
  • Kai Kisand

DOI
https://doi.org/10.3389/fimmu.2020.00838
Journal volume & issue
Vol. 11

Abstract

Read online

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is caused by recessive mutations in the AIRE gene. The hallmark of the disease is the production of highly neutralizing autoantibodies against type I interferons and IL-22. Considering the importance of IL-22 in maintaining mucosal barrier integrity and shaping its microbial community, we sought to study potential changes in the oral cavity in this model of human IL-22 paucity. We found that besides known Th22 cell deficiency, APECED patients have significantly fewer circulating MAIT cells with potential IL-22 secreting capacity. Saliva samples from APECED patients revealed local inflammation, the presence of autoantibodies against IFN-α and IL-22, and alterations in the oral microbiota. Moreover, gene expression data of buccal biopsy samples suggested impaired antimicrobial response and cell proliferation, both of which are processes regulated by IL-22. Our data complement the knowledge gained from mouse models and support the concept of IL-22 being a critical homeostatic cytokine in human mucosal sites.

Keywords